Coca-Cola and PepsiCo land bull ratings at Piper Sandler
Piper Sandler dipped into the beverage sector on Tuesday by issuing new Overweight ratings on Coca-Cola ( NYSE: KO) and ...
Piper initiates on soda stocks; Pepsi, Coca-Cola ‘overweight,’ Dr Pepper ‘neutral'
Piper Sandler initiated coverage on soda stocks, rating PepsiCo (NASDAQ:PEP), Coca-Cola (NYSE:KO) “overweight,” and Neutral on Keurig Dr Pepper (NASDAQ:KDP).
Analyst Downgrade Fuels Further Decline For Celsius (CELH) Shares Amid Sales Concerns And Investor Lawsuit- Hagens Berman
CELH Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO, Jan. 6, 2025 /PRNewswire/ -- Shares of Celsius H ...
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Celsius
If you suffered losses exceeding $75,000 in Celsius between February 29, 2024 and September 4, 2024 and would like to discuss ...
Why PepsiCo Is An Opportunity For Investors With A Long-Term Time Horizon
The uncertainties surrounding PepsiCo Inc's performance in 2025 are already reflected in its stock price, according to Piper ...
Celsius: Hitting Rock Bottom
Celsius Holdings, Inc., an energy drink maker, should have a strong 2025 with growth drivers from Amazon and international ...
Coca-Cola And PepsiCo: Own Both Or Lose Big This Year
PepsiCo and Coca-Cola are both undervalued, and I foresee an appreciable upside in 2025. Click here to read why both PEP and ...
Wells Fargo Reaffirms Their Hold Rating on PepsiCo (PEP)
In a report released today, Christopher Carey from Wells Fargo maintained a Hold rating on PepsiCo (PEP – Research Report), with a price target ...
Mawson Provides Update on Spin Out of Uranium Assets, Name Change, Consolidation and SXG Scheme of Arrangement
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY ...
MBX Biosciences, Inc.: MBX Biosciences Announces Positive Phase 1 Topline Results for MBX 1416 for the Treatment of Post-bariatric Hypoglycemia
Phase 1 results support proceeding to Phase 2 in patients with post-bariatric hypoglycemia (PBH), which is expected to begin in 2H 2025 Phase 1 trial in healthy volunteers showed MBX 1416 was generall ...
Your Money: Getting your finances in order for the new year
As we step into a new year, it’s a perfect time to assess our finances and set goals for a stronger financial future. Here in ...
Singapore Dollar Likely to Weaken on Potentially Higher U.S. Tariffs
The Singapore dollar could weaken to 1.3800 per U.S. dollar in 1Q on potentially higher U.S. tariffs, MUFG Bank said.